Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urucum is a botanical drug and pigment extract derived from the seeds of the *Bixa orellana* plant, native to tropical regions. Its primary active constituents are the carotenoids **bixin** (fat-soluble) and **norbixin** (water-soluble), which provide potent antioxidant, anti-inflammatory, and antimicrobial properties. In clinical dentistry, urucum is utilized as a photosensitizer in **antimicrobial photodynamic therapy (aPDT)**; when activated by blue light (typically 395-480 nm), it generates reactive oxygen species (ROS) that eliminate microorganisms responsible for conditions like halitosis. Beyond dentistry, urucum preparations are studied for their ability to accelerate wound healing by promoting fibroblast proliferation and collagen maturation, and for their potential hypolipidemic effects in managing hypertriglyceridemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on urucum.